Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CIPROFLOXACIN Cause Prothrombin time prolonged? 26 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Prothrombin time prolonged have been filed in association with CIPROFLOXACIN (Ciprofloxacin). This represents 0.1% of all adverse event reports for CIPROFLOXACIN.

26
Reports of Prothrombin time prolonged with CIPROFLOXACIN
0.1%
of all CIPROFLOXACIN reports
1
Deaths
3
Hospitalizations

How Dangerous Is Prothrombin time prolonged From CIPROFLOXACIN?

Of the 26 reports, 1 (3.8%) resulted in death, 3 (11.5%) required hospitalization, and 1 (3.8%) were considered life-threatening.

Is Prothrombin time prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CIPROFLOXACIN. However, 26 reports have been filed with the FAERS database.

What Other Side Effects Does CIPROFLOXACIN Cause?

Drug hypersensitivity (5,266) Arthralgia (3,749) Pain (3,201) Fatigue (3,056) Drug ineffective (2,918) Nausea (2,689) Neuropathy peripheral (2,607) Diarrhoea (2,599) Pain in extremity (2,522) Dyspnoea (2,340)

What Other Drugs Cause Prothrombin time prolonged?

WARFARIN (257) RIVAROXABAN (253) ACETAMINOPHEN (201) ASPIRIN (102) DABIGATRAN ETEXILATE (84) APIXABAN (82) ENOXAPARIN (52) IBUPROFEN (49) METHOTREXATE (49) AMIODARONE (44)

Which CIPROFLOXACIN Alternatives Have Lower Prothrombin time prolonged Risk?

CIPROFLOXACIN vs CIPROFLOXACIN\DEXAMETHASONE CIPROFLOXACIN vs CIPROFLOXACIN\FLUOCINOLONE ACETONIDE CIPROFLOXACIN vs CISAPRIDE CIPROFLOXACIN vs CISATRACURIUM CIPROFLOXACIN vs CISPLATIN

Related Pages

CIPROFLOXACIN Full Profile All Prothrombin time prolonged Reports All Drugs Causing Prothrombin time prolonged CIPROFLOXACIN Demographics